PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  PMID 14551045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic and Additional Vascular Effects of Thiazolidinediones

  2012cited by this paper
• PPAR(gamma) and glucose homeostasis.

  2003cited by this paper
• Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.

  2003cited by this paper
• Peroxisome Proliferator-Activated Receptor &ggr; Ligands Increase Release of Nitric Oxide From Endothelial Cells

  2003cited by this paper
• The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.

  2003cited by this paper
• Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus.

  2003cited by this paper
• Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.

  2002cited by this paper
• Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase

  2002cited by this paper
• Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats.

  2002cited by this paper
• New drug targets for type 2 diabetes and the metabolic syndrome

  2001cited by this paper
• Cardiac function in perfused hearts from diabetic mice.

  2001cited by this paper
• The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.

  2001cited by this paper
• Endothelial dysfunction in diabetes

  2000cited by this paper
• Expression and function of PPARgamma in rat and human vascular smooth muscle cells.

  2000cited by this paper
• Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.

  2000cited by this paper
• The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

  1999cited by this paper
• Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)

  1998cited by this paper
• Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells.

  1998cited by this paper
• Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats.

  1998cited by this paper
• Diabetes mellitus and cardiac function

  1998cited by this paper
• Troglitazone, an insulin sensitizer, increases forearm blood flow in humans.

  1998cited by this paper
• Role for endothelin-1 in angiotensin II-mediated hypertension.

  1997cited by this paper
• Endothelial dysfunction and pathogenesis of diabetic angiopathy.

  1997cited by this paper
• Oxidative Stress and Diabetic Vascular Complications

  1996cited by this paper
• Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus.

  1996cited by this paper
• Cardiac consequences of diabetes mellitus

  1995cited by this paper
• NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium.

  1994cited by this paper
• Role of Oxidative Stress in Development of Complications in Diabetes

  1991cited by this paper
• Diabetes, a New Mutafton in the Mouse

  1966cited by this paper

• Evaluation of an Antioxidative Thermoresponsive Polydiolcitrate Hydrogel in a Novel Diabetic Pig Impaired Wound Healing Model

  2025cites this paper
• Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis.

  2024cites this paper
• A Study to Evaluate the Effect of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors on Oxidative Stress Parameters in Type 2 Diabetes Mellitus Patients

  2024cites this paper
• Sinomenine Hydrochloride Regulates the Apoptosis of Endothelial Cells through PPAR-γ to Alleviate PAH.

  2024cites this paper
• Neuraminidase inhibition improves endothelial function in diabetic mice.

  2023cites this paper
• Endothelial cell dysfunction in cardiac disease: driver or consequence?

  2023cites this paper
• Exercise training and vascular heterogeneity in db/db mice: evidence for regional- and duration-dependent effects

  2023cites this paper
• Bavachin alleviates diabetic nephropathy in db/db mice by inhibition of oxidative stress and improvement of mitochondria function.

  2023cites this paper
• Rosiglitazone restores nitric oxide synthase-dependent reactivity of cerebral arterioles in rats exposed to prenatal alcohol.

  2021cites this paper
• Redox Signaling and Regional Heterogeneity of Endothelial Dysfunction in db/db Mice

  2020cites this paper
• Experimental animal models of coronary microvascular dysfunction

  2020cites this paper
• Carvacrol protects against diabetes-induced hypercontractility in the aorta through activation of the PI3K/Akt pathway.

  2020cites this paper
• Cellular and Functional Effects of Insulin Based Therapies and Exercise on Endothelium.

  2020influential citation
• Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity

  2020cites this paper
• Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance

  2018cites this paper
• Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis

  2018cites this paper
• Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats.

  2018cites this paper
• Enhanced Renal Afferent Arteriolar Reactive Oxygen Species and Contractility to Endothelin-1 Are Associated with Canonical Wnt Signaling in Diabetic Mice

  2018cites this paper
• The Role of Peroxisome Proliferator-Activated Receptor γ in Mediating Cardioprotection Against Ischemia/Reperfusion Injury

  2018cites this paper
• Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options

  2017cites this paper
• Cellular and Molecular Mechanisms of Diabetic Atherosclerosis: Herbal Medicines as a Potential Therapeutic Approach

  2017cites this paper
• Hypoglycaemic and Antioxidant Effects of Dichloromethane: Methanolic Leaf and Stem Bark Extracts of Pappea Capensis from Embu County, Kenya

  2017cites this paper
• Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy?

  2017cites this paper
• Adipose Tissue Hypoxia in Obesity and Its Impact on Preadipocytes and Macrophages: Hypoxia Hypothesis.

  2017cites this paper
• Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction.

  2016cites this paper
• Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis

  2016cites this paper
• Effects of a PPAR -gamma receptor agonist and an angiotensin receptor antagonist on aortic contractile responses to alpha receptor agonists in diabetic and/or hypertensive rats

  2016cites this paper
• RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vessels

  2016cites this paper
• Effects of rosiglitazone (PPAR γ agonist) on the myocardium in non‐hypertensive diabetic rats 罗格列酮（PPAR γ 激动剂）对非高血压糖尿病大鼠的心肌的影响

  2015cites this paper
• Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?

  2015cites this paper
• Cardiac NO signalling in the metabolic syndrome

  2015cites this paper
• The relationship between obesity and bone mineral density: evidence for a role of peroxisome proliferator-activated receptor gamma.

  2015cites this paper
• Impaired coronary collateral growth: miR-shaken neutrophils caught in the act.

  2015cites this paper
• Damage to vascular endothelial cells by high insulin levels is associated with increased expression of ChemR23, and attenuated by PPAR-gamma agonist, rosiglitazone.

  2015cites this paper
• Endothelial dysfunction, obesity and insulin resistance.

  2014cites this paper
• PPARγ and NAD(P)H oxidase system interaction in glycerol-induced acute renal failure: role of gp91phox subunit of NAD(P)H oxidase

  2014cites this paper
• Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies

  2014cites this paper
• Peroxynitrite Disrupts Endothelial Caveolae Leading to eNOS Uncoupling and Diminished Flow-Mediated Dilation in Coronary Arterioles of Diabetic Patients

  2014cites this paper
• Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review

  2014cites this paper
• A Radical Concept on Caveolae and Endothelial Dysfunction in Coronary Microvascular Disease in Diabetes

  2014cites this paper
• Ca(2+) handling alterations and vascular dysfunction in diabetes.

  2014cites this paper
• The increased gastroprotective effect of pioglitazone in cholestatic rats: role of nitric oxide and tumour necrosis factor alpha

  2014cites this paper
• Activation of PPAR-&ggr; by Pioglitazone Attenuates Oxidative Stress in Aging Rat Cerebral Arteries Through Upregulating UCP2

  2014cites this paper
• Pathophysiology of Coronary Vascular Remodeling: Relationship With Traditional Risk Factors for Coronary Artery Disease

  2014cites this paper
• Sweet sorghum (Sorghum bicolor) biomass, generated from biofuel production, as a reservoir of bioactive compounds for human health

  2014cites this paper
• Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone.

  2013cites this paper
• Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: The role of nitric oxide and IL-1β

  2013cites this paper
• The effect of pioglitazone on non-pregnant female genital tract in experimental diabetes mellitus.

  2013cites this paper
• Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation.

  2013cites this paper
• Insulin, cognition, and dementia.

  2013cites this paper
• Inhibition of PPARγ during rat pregnancy causes intrauterine growth restriction and attenuation of uterine vasodilation

  2013influential citation
• Selective Up-Regulation of Arginase-1 in Coronary Arteries of Diabetic Patients

  2013cites this paper
• Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes

  2013cites this paper
• Nutritional Countermeasures Targeting Reactive Oxygen Species in Cancer: From Mechanisms to Biomarkers and Clinical Evidence

  2013cites this paper
• PPARs: a potential target for a disease-modifying strategy in stroke.

  2013cites this paper
• Role of caveolae in shear stress-mediated endothelium-dependent dilation in coronary arteries.

  2013cites this paper
• on the effect of rosiglitazon on telomere dynamics with molecular methods in rats

  2012cites this paper
• Endocannabinoids and the cardiovascular response to stress

  2012cites this paper
• Modulation of baroreflex function by rosiglitazone in prediabetic hyperglycemic rats.

  2012cites this paper
• Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats

  2012cites this paper
• Acute Rosiglitazone Treatment during Reperfusion after Hyperglycemic Stroke is Neuroprotective Not Vascular Protective

  2012cites this paper
• Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats

  2012cites this paper
• Rosiglitazone preserves pulmonary vascular function in lambs with increased pulmonary blood flow

  2012cites this paper
• PPARγ ligands regulate NADPH oxidase, eNOS, and barrier function in the lung following chronic alcohol ingestion.

  2012cites this paper
• Rosiglitazone, a peroxisome proliferator‐activated receptor γ stimulant, abrogates diabetes‐evoked hypertension by rectifying abnormalities in vascular reactivity

  2012cites this paper
• Pioglitazone treatment increases COX‐2‐derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function

  2012cites this paper
• Protective effect of paricalcitol on cyclosporine-induced renal injury in rats.

  2012cites this paper
• Microvascular responsiveness in obesity: implications for therapeutic intervention

  2012cites this paper
• Regional heterogeneity of the vascular dysfunction in db/db mice : role of reactive oxygen species

  2012cites this paper
• PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system?

  2011cites this paper
• Weight and inflammation are the major determinants of vascular dysfunction in the aortae of db/db mice

  2011cites this paper
• Anti‐Stroke Profile of Thiazolidin‐4‐One Derivatives in Focal Cerebral Ischemia Model in Rat

  2011cites this paper
• Increased availability of angiotensin AT1 receptors leads to sustained arterial constriction to angiotensin II in diabetes – role for Rho‐kinase activation

  2011cites this paper
• Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway.

  2011cites this paper
• Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte.

  2011cites this paper
• The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria

  2011cites this paper
• Nox2-derived ROS in PPARγ signaling and cell-cycle progression of lung alveolar epithelial cells

  2011cites this paper
• Peroxisome proliferator-activated receptor-γ and the endothelium: implications in cardiovascular disease

  2011cites this paper
• Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes.

  2011cites this paper
• Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells

  2011cites this paper
• NADPH oxidases in cardiovascular disease.

  2010cites this paper
• Gastroprotective effects of the insulin sensitizers rosiglitazone and metformin against indomethacin‐induced gastric ulcers in Type 2 diabetic rats

  2010cites this paper
• Coronary microvascular dysfunction in diabetes mellitus: A review.

  2010cites this paper
• EFFECTS OF ROSIGLITAZONE ON NITROGLYCERIN-INDUCED ENDOTHELIAL DYSFUNCTION

  2010cites this paper
• Direct relationship between levels of TNF-α expression and endothelial dysfunction in reperfusion injury

  2010cites this paper
• The effects of rosiglitazone and high glucose on protein expression in endothelial cells.

  2010cites this paper
• Renal function and vasomotor activity in mice lacking the Cyp4a14 gene

  2010cites this paper
• Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse.

  2010cites this paper
• Impact of High Fat Dietary Treatment and Nox2-Deficiency on Prooxidant and Antioxidant Enzyme Expression in the Heart

  2010cites this paper
• Quercetin enhances adiponectin secretion by a PPAR-gamma independent mechanism.

  2010cites this paper
• Literature-based discovery of diabetes- and ROS-related targets

  2010cites this paper
• Interaction of oxidative stress, nitric oxide and peroxisome proliferator activated receptor gamma in acute renal failure.

  2010cites this paper
• PPARγ Expression After a High‐fat Meal Is Associated With Plasma Superoxide Dismutase Activity in Morbidly Obese Persons

  2010influential citation
• PPARγ inhibits inflammatory reaction in oxidative stress induced human diploid fibloblast

  2010cites this paper
• Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity.

  2010cites this paper
• Peroxisome proliferator-activated receptor-gamma(PPARgamma) agonist improves coronary artery endothelial function in diabetic patients with coronary artery disease.

  2010cites this paper
• Direct antiatherosclerotic effects of PPAR agonists

  2009cites this paper
• Activation of prostaglandin E 2 EP 1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes

  2009cites this paper
• Mechanisms of coronary microvascular adaptation to obesity.

  2009cites this paper
• Rosiglitazone inhibits high glucose-induced apoptosis in human umbilical vein endothelial cells through the PI3K/Akt/eNOS pathway.

  2009cites this paper